Product Description
Brand Acon
F131-40211 Serum/ Plasma/ WB
Pack Size 25T
CAT No F131-40311
Biomarker Cardiac
The Myoglobin FIA Test is a fluorescence immunoassay that is used with the FIAflex Fluorescent Immunoassay Analyzer for the quantitative detection of Myoglobin (MYO) in human serum, plasma and venous whole blood. It is useful as an aid in management and monitoring of acute myocardial infarction (AMI).
Advanced Technology for Rapid Cardiac AssessmentLeveraging sandwich immunodetection and fluorescent immunoassay (FIA) technology, the Acon FIAflex Myoglobin FIA Test provides fast and reliable results for myocardial infarction detection. The test is designed to deliver quantitative results with high sensitivity, making it an invaluable tool for early cardiac marker diagnosis.
User-Friendly Design and OperationThe kit includes all necessary components-test cassettes, buffer, and an instruction manual-and requires only 75 L of specimen. Operation is straightforward: simply add the sample, apply the buffer, and read the results with the FIAflex Analyzer. The silent and portable design allows for flexible and convenient use in various clinical environments.
Regulatory Compliance and Safety AssuredCertified with CE marking and complying with IVD regulations, the Acon FIAflex Myoglobin FIA Test ensures diagnostic-grade performance and safety. Each batch is carefully labeled with a lot number for traceability, and the kit offers a shelf life of 18 months when stored between 2-30C, protected from light.
FAQ's of Acon FIAflex Myoglobin FIA Test:
Q: How does the Acon FIAflex Myoglobin FIA Test detect cardiac markers?
A: This test utilizes a sandwich immunodetection method combined with fluorescent immunoassay (FIA) technology. When the sample is added, myoglobin in the specimen binds to specific antibodies on the cassette, and the resulting reaction is measured quantitatively by the FIAflex Analyzer within 15 minutes.
Q: What types of specimens can be used with the test?
A: The test is validated for use with human whole blood, serum, or plasma. Simply collect 75 L of the chosen specimen following the instructions provided, and proceed according to the kit's protocol.
Q: When should the test be used and who benefits from it?
A: The test is intended for early detection of myocardial infarction. Healthcare professionals can use it in clinical labs or point-of-care environments to rapidly assess patients presenting with acute chest pain or suspected cardiac events, supporting early intervention and improved patient outcomes.
Q: Where is the test processed and how are results obtained?
A: The test must be processed using the FIAflex Analyzer, which reads and interprets the fluorescence intensity generated by the immunoreaction. Results are available on the analyzer's display within 15 minutes after sample processing.
Q: What is the correct process for using the test kit?
A: To perform the test, apply 75 L of specimen to the sample well, add the supplied buffer, insert the cassette into the FIAflex Analyzer, and follow on-screen instructions. Ensure you use aseptic techniques and refer to the instruction manual for detailed steps.
Q: What are the storage requirements and shelf life of the kit?
A: Store the test kit at temperatures between 2-30C and protect it from light. The included components remain stable for up to 18 months from the date of manufacture, as indicated on the packaging.
Q: What are the key benefits of using the Acon FIAflex Myoglobin FIA Test?
A: This test delivers high sensitivity and specificity for early myocardial infarction detection, provides rapid and quantitative results, and is both user-friendly and portable. The diagnostic-grade, CE-marked kit supports clinical decisions with high accuracy and fast turnaround.